Advertisement
Screener

OPKO Health, Inc. (OPK) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

OPKO Health, Inc. Comprehensive Income

OPKO Health, Inc. (OPK) reported Comprehensive Income of -$9.32 million for the 3-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-28

  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$9.32M.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$61.32M.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$26.81M.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $20.89M, a 34.56% decline year-over-year.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$190.57M.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$71.32M.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$183.57M.
  • OPKO Health, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$341.23M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed
2026-06-30-$9.32M
10-Q/A · filed 2026-08-28
-$70.64M
10-Q/A · filed 2026-08-28
-$97.45M
derived: sum of 3 quarters · filed 2026-08-28
-$76.55M
derived: sum of 4 quarters · filed 2026-08-28
2026-03-31-$61.32M
10-Q/A · filed 2026-08-28
-$88.13M
derived: sum of 2 quarters · filed 2026-08-28
-$67.23M
derived: sum of 3 quarters · filed 2026-08-28
-$195.40M
derived: sum of 4 quarters · filed 2026-08-28
2025-12-31-$26.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$5.91M
derived: sum of 2 quarters · filed 2026-02-26
-$134.08M
derived: sum of 3 quarters · filed 2026-08-28
-$190.57M
10-K · filed 2026-02-26
2025-09-30$20.89M
10-Q · filed 2025-10-29
-$107.27M
derived: sum of 2 quarters · filed 2026-08-28
-$163.76M
10-Q · filed 2025-10-29
-$166.25M
derived: sum of 4 quarters · filed 2026-08-28
2025-06-30-$128.16M
10-Q/A · filed 2026-08-28
-$184.65M
10-Q/A · filed 2026-08-28
-$187.14M
derived: sum of 3 quarters · filed 2026-08-28
-$155.21M
derived: sum of 4 quarters · filed 2026-08-28
2025-03-31-$56.49M
10-Q/A · filed 2026-08-28
-$58.98M
derived: sum of 2 quarters · filed 2026-08-28
-$27.05M
derived: sum of 3 quarters · filed 2026-08-28
-$38.81M
derived: sum of 4 quarters · filed 2026-08-28
2024-12-31-$2.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$29.44M
derived: sum of 2 quarters · filed 2026-02-26
$17.68M
derived: sum of 3 quarters · filed 2026-02-26
-$71.32M
10-K · filed 2026-02-26
2024-09-30$31.93M
10-Q · filed 2025-10-29
$20.17M
derived: sum of 2 quarters · filed 2025-10-29
-$68.84M
10-Q · filed 2025-10-29
-$126.85M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$11.76M
10-Q · filed 2025-07-31
-$100.76M
10-Q · filed 2025-07-31
-$158.78M
derived: sum of 3 quarters · filed 2026-02-26
-$252.81M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$89.00M
10-Q · filed 2025-05-01
-$147.02M
derived: sum of 2 quarters · filed 2026-02-26
-$241.05M
derived: sum of 3 quarters · filed 2026-02-26
-$260.02M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$58.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$152.04M
derived: sum of 2 quarters · filed 2026-02-26
-$171.01M
derived: sum of 3 quarters · filed 2026-02-26
-$183.57M
10-K · filed 2026-02-26
2023-09-30-$94.03M
10-Q · filed 2024-11-07
-$113.00M
derived: sum of 2 quarters · filed 2024-11-07
-$125.55M
10-Q · filed 2024-11-07
-$196.08M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30-$18.97M
10-Q · filed 2024-08-07
-$31.53M
10-Q · filed 2024-08-07
-$102.05M
derived: sum of 3 quarters · filed 2025-03-03
-$197.00M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31-$12.55M
10-Q · filed 2024-05-07
-$83.08M
derived: sum of 2 quarters · filed 2025-03-03
-$178.03M
derived: sum of 3 quarters · filed 2025-03-03
-$297.44M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31-$70.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$165.47M
derived: sum of 2 quarters · filed 2025-03-03
-$284.88M
derived: sum of 3 quarters · filed 2025-03-03
-$341.23M
10-K · filed 2025-03-03
2022-09-30-$94.95M
10-Q · filed 2023-11-06
-$214.35M
derived: sum of 2 quarters · filed 2023-11-06
-$270.70M
10-Q · filed 2023-11-06
-$355.05M
derived: sum of 4 quarters · filed 2024-03-01
2022-06-30-$119.41M
10-Q · filed 2023-08-03
-$175.76M
10-Q · filed 2023-08-03
-$260.11M
derived: sum of 3 quarters · filed 2024-03-01
-$241.36M
derived: sum of 4 quarters · filed 2024-03-01
2022-03-31-$56.35M
10-Q · filed 2023-05-03
-$140.70M
derived: sum of 2 quarters · filed 2024-03-01
-$121.95M
derived: sum of 3 quarters · filed 2024-03-01
-$147.21M
derived: sum of 4 quarters · filed 2024-03-01
2021-12-31-$84.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
-$65.60M
derived: sum of 2 quarters · filed 2024-03-01
-$90.85M
derived: sum of 3 quarters · filed 2024-03-01
-$56.41M
10-K · filed 2024-03-01
2021-09-30$18.75M
10-Q · filed 2022-11-08
-$6.51M
derived: sum of 2 quarters · filed 2022-11-08
$27.93M
10-Q · filed 2022-11-08
$61.02M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$25.26M
10-Q · filed 2022-08-04
-$12.82M
10-Q · filed 2021-07-29
$5.82M
10-Q · filed 2022-08-04
$9.19M
10-Q · filed 2021-07-29
$42.28M
derived: sum of 3 quarters · filed 2023-02-27
$74.29M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$22.01M
10-Q · filed 2022-05-09
$67.53M
derived: sum of 2 quarters · filed 2023-02-27
$99.55M
derived: sum of 3 quarters · filed 2023-02-27
$137.69M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$45.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$77.54M
derived: sum of 2 quarters · filed 2023-02-27
$115.68M
derived: sum of 3 quarters · filed 2023-02-27
$48.43M
10-K · filed 2023-02-27
2020-09-30$32.02M
10-Q · filed 2021-10-28
$70.16M
derived: sum of 2 quarters · filed 2021-10-28
$2.91M
10-Q · filed 2021-10-28
2020-06-30$38.14M
10-Q · filed 2021-07-29
-$29.11M
10-Q · filed 2021-07-29
2020-03-31-$67.25M
10-Q · filed 2021-04-28
2019-12-31-$316.86M
10-K · filed 2022-03-01
2018-12-31-$172.64M
10-K · filed 2021-02-18
2017-12-31-$278.77M
10-K · filed 2020-03-02
2017-03-31-$28.94M
10-Q · filed 2017-05-10
2016-09-30-$7.83M
10-Q · filed 2016-11-07
$1.38M
derived: sum of 2 quarters · filed 2016-11-07
-$5.17M
10-Q · filed 2016-11-07
-$5.11M
derived: sum of 4 quarters · filed 2017-05-10
2016-06-30$9.21M
10-Q · filed 2016-08-08
$2.66M
10-Q · filed 2016-08-08
$2.72M
derived: sum of 3 quarters · filed 2017-05-10
$128.85M
derived: sum of 4 quarters · filed 2017-05-10
2016-03-31-$6.55M
10-Q · filed 2017-05-10
-$6.49M
derived: sum of 2 quarters · filed 2017-05-10
$119.64M
derived: sum of 3 quarters · filed 2017-05-10
$75.50M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$58.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$126.19M
derived: sum of 2 quarters · filed 2016-11-07
$82.05M
derived: sum of 3 quarters · filed 2016-11-07
-$40.17M
10-K · filed 2016-02-29
2015-09-30$126.13M
10-Q · filed 2016-11-07
$81.99M
derived: sum of 2 quarters · filed 2016-11-07
-$40.23M
10-Q · filed 2016-11-07
-$96.90M
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30-$44.14M
10-Q · filed 2016-08-08
-$166.37M
10-Q · filed 2016-08-08
-$223.03M
derived: sum of 3 quarters · filed 2016-08-08
-$280.70M
derived: sum of 4 quarters · filed 2016-08-08
2015-03-31-$122.22M
10-Q · filed 2016-05-09
-$178.89M
derived: sum of 2 quarters · filed 2016-05-09
-$236.56M
derived: sum of 3 quarters · filed 2016-05-09
-$263.14M
derived: sum of 4 quarters · filed 2016-05-09
2014-12-31-$56.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$114.34M
derived: sum of 2 quarters · filed 2016-02-29
-$140.91M
derived: sum of 3 quarters · filed 2016-02-29
-$187.48M
10-K · filed 2016-02-29
2014-09-30-$57.67M
10-Q · filed 2015-11-09
-$84.25M
derived: sum of 2 quarters · filed 2015-11-09
-$130.81M
10-Q · filed 2015-11-09
-$147.02M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$26.57M
10-Q · filed 2015-08-05
-$73.14M
10-Q · filed 2015-08-05
-$89.34M
derived: sum of 3 quarters · filed 2016-02-29
-$148.94M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$46.57M
10-Q · filed 2015-05-11
-$62.77M
derived: sum of 2 quarters · filed 2016-02-29
-$122.36M
derived: sum of 3 quarters · filed 2016-02-29
-$131.02M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$16.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$75.79M
derived: sum of 2 quarters · filed 2016-02-29
-$84.45M
derived: sum of 3 quarters · filed 2016-02-29
-$118.34M
10-K · filed 2016-02-29
-$118.77M
10-K · filed 2014-03-03
2013-09-30-$59.59M
10-Q · filed 2014-11-07
-$68.25M
derived: sum of 2 quarters · filed 2014-11-07
-$102.15M
10-Q · filed 2014-11-07
-$102.66M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$8.66M
10-Q · filed 2014-08-11
-$42.55M
10-Q · filed 2014-08-11
-$43.07M
derived: sum of 3 quarters · filed 2015-02-27
-$50.99M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$33.90M
10-Q · filed 2014-05-09
-$34.41M
derived: sum of 2 quarters · filed 2015-02-27
-$42.34M
derived: sum of 3 quarters · filed 2015-02-27
-$48.83M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$516.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$8.44M
derived: sum of 2 quarters · filed 2015-02-27
-$14.93M
derived: sum of 3 quarters · filed 2015-02-27
-$22.60M
10-K · filed 2015-02-27
-$24.84M
10-K · filed 2013-03-18
2012-09-30-$7.92M
10-Q · filed 2013-11-12
-$14.41M
derived: sum of 2 quarters · filed 2013-11-12
-$22.08M
10-Q · filed 2013-11-12
-$3.73M
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30-$6.49M
10-Q · filed 2013-08-09
$6.49M
10-Q · filed 2012-08-09
-$14.16M
10-Q · filed 2013-08-09
$4.20M
derived: sum of 3 quarters · filed 2014-03-03
-$7.36M
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31-$7.67M
10-Q · filed 2013-05-10
$10.69M
derived: sum of 2 quarters · filed 2014-03-03
-$874.00K
derived: sum of 3 quarters · filed 2014-03-03
-$6.50M
derived: sum of 4 quarters · filed 2014-03-03
2011-12-31$18.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
$6.80M
derived: sum of 2 quarters · filed 2014-03-03
$1.17M
derived: sum of 3 quarters · filed 2014-03-03
-$5.68M
10-K · filed 2014-03-03
2011-09-30-$11.56M
10-Q · filed 2012-11-09
-$17.19M
derived: sum of 2 quarters · filed 2012-11-09
-$24.03M
10-Q · filed 2012-11-09
2011-06-30-$5.63M
10-Q · filed 2012-08-09
-$12.47M
10-Q · filed 2012-08-09
2011-03-31-$6.85M
10-Q · filed 2012-05-10
2010-12-31-$19.94M
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
HARROW, INC. (HROW)United States$1.240B-42.77
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93